We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

The Immune System – News and Features

News

Developments Improve Safety of Stem Cell Transplantation in the Treatment of Leukaemia

Study shows that a 'suicide' gene can be used to cut short rejection reactions following stem cell transplants.
News

Researchers Identify Roles of Gene Mutations Causing Lupus in Mice

Researchers find that a defect in the Ly108 gene causes immune cells called B-cells to attack the body’s healthy cells.
News

Carrington Receives European Patent Protection for Stabilization of Proteins and Peptides

Focuses on stabilization of unstable molecules expands drug delivery base for proteins and peptides.
News

Lpath Humanizes Its Anti-S1P Antibody Sphingomab™

Important milestone achieved in development of anti-S1P antibody for treatment of cancer and other major diseases.
News

Gene Expression Profiling can Diagnose Burkitt's Lymphoma

Burkitt's lymphoma and diffuse large B-cell lymphoma cells appear similar when viewed under a microscope.
News

Inovio at ASGT 9th Annual Meeting

Inovio’s presentation showcase potential for electroporation in delivering DNA vaccines.
News

ThermoGenesis and Netcord Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims

These patents relate to the collection, cryopreservation and storage of hematopoietic stem cell - containing umbilical cord blood.
News

GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research

GSK has licensed from LICR a significant number of cancer antigens expressed in a large variety of cancers.
News

Life Science Pharmaceuticals Acquires Monoclonal Antibody Programs from LICR

Company plans to exploit the targeting attributes of certain product candidates by attaching tumor-fighting payloads to the antibodies.
News

Moffitt and Inovio Announce Positive Results from Human Study of Plasmid DNA Delivery Using Electroporation

Collaborators encouraged by interim data from phase I clinical study of patients with malignant melanoma.
Advertisement